Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results

SAN DIEGO, May 14, 2024 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal third quarter ended March 31, 2024,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks